{
    "title": "Biogen says ALS drug shows clinical benefit in new data analysis",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11236803/Biogen-says-ALS-drug-shows-clinical-benefit-new-data-analysis.html",
    "date": "2022-09-21",
    "keywords": [
        "drug",
        "biogen",
        "analysis",
        "tofersen",
        "latestage",
        "trial",
        "study",
        "roy",
        "use",
        "disease",
        "company",
        "approval",
        "cord",
        "medicine",
        "strength",
        "gene",
        "initiation",
        "treatment",
        "form",
        "sclerosis",
        "progression",
        "priority",
        "review",
        "food",
        "administration",
        "decision",
        "jan",
        "lou",
        "brain",
        "paralysis",
        "death",
        "cause",
        "openextension",
        "phase",
        "type",
        "journal",
        "october",
        "goal",
        "improvement",
        "status",
        "muscle",
        "control",
        "duration",
        "effect",
        "preservation",
        "function",
        "breathing",
        "dr",
        "miller",
        "lead",
        "researcher",
        "center",
        "director",
        "washington",
        "university",
        "school",
        "st",
        "louis",
        "interview",
        "im",
        "response",
        "course",
        "accumulation",
        "protein",
        "sod1",
        "portion",
        "headache",
        "inflammation",
        "swelling",
        "nerve",
        "reporting",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}